Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
Sze Ling ChanLi Shia NgXueying GohChor Hiang SiowHan Lee GohBoon Cher GohTimothy CheoKwok Seng LohLiam R BrunhamPublished in: Head & neck (2018)
Although cisplatin led to high frequency hearing impairment from about 3 months posttreatment, RT conferred no significant hearing impairment in the first 2 years.